SABRINA JAMIEL: Open Payments
NPI 1336757137 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,122 in 165 payments from 20 companies in 2025. Trend: 2023 $2,243 · 2024 $5,122 · 2025 $4,122
Food & beverage: $3,954Education: $168
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $596 |
| Arcutis Biotherapeutics, Inc. | 15 | $534 |
| ABBVIE INC. | 24 | $451 |
| Galderma Laboratories, L.P. | 21 | $447 |
| Amgen Inc. | 7 | $289 |
| Regeneron Healthcare Solutions, Inc. | 4 | $264 |
| Incyte Corporation | 7 | $242 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $185 |
| GENZYME CORPORATION | 6 | $160 |
| Botanix SB Inc | 11 | $155 |
Products named: Bimzelx, DUPIXENT, OTEZLA, Zoryve, NEMLUVIO, OPZELURA, RINVOQ, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
